Dutasteride and oral minoxidil made me more attractive / younger. Now girlfriend doesn’t recognize the old me 😅
    Progress Pictures 10/9/2024

    From the encyclopedia
    Dutasteride →

    5-alpha reductase inhibitor that blocks both enzyme types, a stronger DHT blocker than finasteride

    Minoxidil →

    Vasodilator used on the scalp and, at low doses, as a tablet

    At a glance
    In this success story post, the primary subjects mentioned are
    💊 Dutasteride (oral) 0.5mg daily 4 years
    💊 Minoxidil (oral) 2.5mg daily 4 years
    the tone is 😀 positive with impressive results.

    Other terms

    Dutasteride and oral minoxidil improved the user's hair thickness, darkness, and curliness, making them look more attractive and younger. The user takes 0.5mg of dutasteride and 2.5mg of minoxidil daily.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results

      research Interventions for female pattern hair loss

      21 citations , May 2016 in “The Cochrane library”
      This review found that while topical minoxidil is effective for treating female pattern hair loss, finasteride showed no more effectiveness than placebo, and low-level laser therapy increased hair count but with inconsistent results.

      research Treatment of Chemotherapy Induced Alopecia

      July 2026 in “IntechOpen eBooks”
      This review highlights the challenges and management strategies associated with persistent chemotherapy-induced alopecia, detailing the psychosocial impacts, follicular pathobiology, and available treatments such as scalp cooling and minoxidil, ultimately proposing a clinical algorithm to transform it into a preventable and manageable condition.

      research New investigational drugs for androgenetic alopecia

      48 citations , April 2013 in “Expert Opinion on Investigational Drugs”
      This article reviews emerging treatments for androgenetic alopecia, including topical 5-alpha-reductase inhibitors and prostaglandin modulators, but reports no clinical results and calls for further efficacy evidence, especially for PRP.

      research Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia

      38 citations , March 2017 in “Expert Opinion on Investigational Drugs”
      This review examines the potential of bimatoprost for treating various types of eyelash and eyebrow hypotrichosis, discussing its pharmacological properties but providing no new clinical results.

      research Eyebrow and Eyelash Alopecia: A Clinical Review

      6 citations , October 2022 in “American journal of clinical dermatology”
      This review provides an updated overview of the symptomatology, diagnosis, trichoscopy findings, and treatment options for eyebrow and eyelash alopecia, but it reports no new experimental results.